您的位置: 首页 > 农业专利 > 详情页

INTRATUMORAL ADMINISTRATION OF PARTICLES CONTAINING A TOLL-LIKE RECEPTOR 9 AGONIST AND A TUMOR ANTIGEN FOR TREATING CANCER
专利权人:
DYNAVAX TECHNOLOGIES CORPORATION
发明人:
GUIDUCCI, Cristiana,NAIK, Edwina,MILLEY, Robert,CHIPMAN, Stewart
申请号:
SG11201808913W
公开号:
SG11201808913WA
申请日:
2017.04.14
申请国别(地区):
SG
年份:
2018
代理人:
摘要:
The present disclosure relates to methods for treating cancer by intratumoral delivery of particles containing a Toll-like receptor 9 agonist (TLR9) and a tumor antigen, in which the TLR9 agonist is a polynucleotide or a chimeric compound thereof. The methods of the present disclosure involve injection of the particles into at least one tumor, and are effective for treating both injected and uninjected tumors of a mammalian subject. Additionally, the present disclosure provides immunogenic compositions containing the particles, as well as methods of manufacture thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充